BioCentury | Aug 18, 2020
Deals
Lilly’s global deal for Innovent PD-1 could lead to U.S. approval, adds more cash for biotech’s R&D
...death 1 ligand 1TIGIT - T cell immunoreceptor with Ig and ITIM domains
Paul Bonanos
Tyvyt, sintilimab (IBI308)
Eli...